Delve into the efficacy and safety data for the antibody–drug conjugates currently approved by the US FDA across tumor types such as hematologic, genitourinary, and gynecologic cancers.
Retroperitoneal lymph node dissection is a valuable tool in the management of testicular cancer. Gain an understanding of its key role in diagnosis and staging, and beyond.
Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.
Active surveillance (AS) is a strategy recommended by the European Association of Urology (EAU) for patients presenting with low or favourable intermediate-risk prostate cancer (PCa) [ 1 ]. AS involves identifying optimal timings for curative …
With the age of monoclonal antibodies (mabs) ushered in by Köhler and Milstein’s 1975 breakthrough in hybridoma technology, there came potential for developing specific, targeted cancer therapeutics. One of the most significant has been …
The global incidence of cancer is on the increase. It is expected that cancer will become the most frequent cause of death in most countries worldwide during the twenty-first century [ 1 , 2 ]. Despite advances in early detection and treatment …
Hormonal treatments (HT) for prostate cancer (e.g., androgen deprivation therapy) yield clinical and survival benefits, yet adverse cognitive changes may be a side effect. Since psychosocial factors are largely modifiable, interventions targeting …
An expert-led symposium exploring the most pertinent issues in cardio-oncology, with a focus on the new ESC guidelines. Highlights include preventative approaches in cardio-oncology, toxicity risk-stratification strategies, the clinical management of myocarditis as an adverse effect of immune checkpoint inhibitor-treatments, and the utility of biomarkers in long-term follow-up of cardiovascular disease risk in cancer patients.
Adjuvant pembrolizumab treatment after resection of lung metastases in a patient with renal cell carcinoma may have led to lung erosion that resulted in a pneumothorax.
The first reported case of PERM associated with anti-glycine receptor antibodies in a patient with bladder cancer. PERM, a stiff-person syndrome, has paraneoplastic etiology in about 20% of cases.
Active surveillance (AS) is a strategy recommended by the European Association of Urology (EAU) for patients presenting with low or favourable intermediate-risk prostate cancer (PCa) [ 1 ]. AS involves identifying optimal timings for curative …
Testicular cancer (TC) is the most common solid malignancy in young men, with rising incidence rates [ 1 ]. As the disease has an excellent cure rate and affects mostly young men, TC survivors bear a significant risk of suffering from long-term …
Cancer screening behaviors in Muslims are under-researched, and there is limited data on how it relates to their unique cultural and religious beliefs. We assessed cancer prevention and screening-related health needs in the Washington DC area. We …
The global incidence of cancer is on the increase. It is expected that cancer will become the most frequent cause of death in most countries worldwide during the twenty-first century [ 1 , 2 ]. Despite advances in early detection and treatment …